Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBSSL in Preterm Infants
NCT00659243Phase 2Completed
- Sponsor
- Sobi
- Start
- Mar 2008
- Primary completion
- Feb 2010
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of bucelipase alfa in fat malabsorption, sponsored by Sobi. Started Mar 2008; status: completed.
02
Drugs
bucelipase alfa
03
Conditions
fat malabsorption
Beyond the preview
Go deeper on NCT00659243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659243.